Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2017; 42(3): 385-389


Evaluation of anti-inflammatory effect of natural dietary supplement Beta vulgaris (Beet root) in animal models of inflammation

Sana Sarfaraz, Rahila Najam.




Abstract

Objective: Beta vulgaris is an important part of daily diet and is consumed in salads. Current study was conducted to investigate the anti-inflammatory potential of lyophilized beet root powder.
Methodology: Albino rats weighing 140-200gm were chosen for this study. They were divided into six equal groups. For ethanoic acid induced paw edema model, group I was labeled as control and was orally given 1ml distilled water; groups II was given Ibuprofen as standard (400mg/70kg) and group III was given aqueous solution of lyophilized Beta vulgaris at dose of 500mg/kg. 30 minutes after giving these treatments 0.1 ml of 1% w/v ethanoic acid was administered in the subplantar tissue of rat paw. For carrrageenan induced paw edema method, group I (a), group II (a) and group III (a) were given same treatment as above divided groups; only difference was that they were administered 0.1ml of 1% carrageenan in subplantar tissue of rat paw after oral treatment. Swelling of paw was measured using Plethysmometer.
Results: Beta vulgaris had highly significant anti-inflammatory activity (p

Key words: Beta vulgaris, carrageenan, ethanoic acid, inflammation.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.